Terms: = Sarcomas AND EXT1, ttv, 2131, ENSG00000182197, EXT, Q16394
65 results:
1. Identification of LGR4 as a prognostic biomarker in KRAS-mutant lung adenocarcinoma: Evidence from integrated bioinformatics analysis.
Dodin Y
Medicine (Baltimore); 2023 Nov; 102(46):e36084. PubMed ID: 37986325
[TBL] [Abstract] [Full Text] [Related]
2. Prevalence and clinical implications of germline pathogenic variants in cancer predisposing genes in young patients across sarcoma subtypes.
Carvalho NA; Santiago KM; Maia JML; Costa FD; Formiga MN; Soares DCQ; Paixão D; Mello CAL; Costa CMLD; Rocha JCCD; Rivera B; Carraro DM; Torrezan GT
J Med Genet; 2023 Dec; 61(1):61-68. PubMed ID: 37536918
[TBL] [Abstract] [Full Text] [Related]
3. Prediction of KRAS
Srisongkram T; Khamtang P; Weerapreeyakul N
J Mol Graph Model; 2023 Jul; 122():108466. PubMed ID: 37058997
[TBL] [Abstract] [Full Text] [Related]
4. Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment Options.
Tlemsani C; Larousserie F; De Percin S; Audard V; Hadjadj D; Chen J; Biau D; Anract P; Terris B; Goldwasser F; Pasmant E; Boudou-Rouquette P
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674874
[TBL] [Abstract] [Full Text] [Related]
5. Drug Repurposing against KRAS Mutant G12C: A Machine Learning, Molecular Docking, and Molecular Dynamics Study.
Srisongkram T; Weerapreeyakul N
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614109
[TBL] [Abstract] [Full Text] [Related]
6. Secondary peripheral chondrosarcoma arising in solitary osteochondroma: variables influencing prognosis and survival.
Righi A; Pacheco M; Cocchi S; Asioli S; Gambarotti M; Donati DM; Evangelista A; Gnoli M; Locatelli M; Mordenti M; Boarini M; Brizola E; Pedrini E; Sangiorgi L
Orphanet J Rare Dis; 2022 Feb; 17(1):74. PubMed ID: 35193636
[TBL] [Abstract] [Full Text] [Related]
7. An update on the imaging of diaphyseal aclasis.
Ellatif M; Sharif B; Lindsay D; Pollock R; Saifuddin A
Skeletal Radiol; 2021 Oct; 50(10):1941-1962. PubMed ID: 33791832
[TBL] [Abstract] [Full Text] [Related]
8. Utility of 18F-FDG-PET/CT in management and prognostication of treatment naïve late-stage soft tissue sarcomas.
Singh TP; Sharma A; Sharma A; Bakhshi S; Patel C; Pandey AK; Dhamija E; Batra A; Kumar R
Nucl Med Commun; 2021 Jul; 42(7):818-825. PubMed ID: 33741856
[TBL] [Abstract] [Full Text] [Related]
9. Droplet-digital PCR reveals frequent mutations in TERT promoter region in breast fibroadenomas and phyllodes tumours, irrespective of the presence of MED12 mutations.
Otsuji K; Sasaki T; Tanabe M; Seto Y
Br J Cancer; 2021 Jan; 124(2):466-473. PubMed ID: 33046803
[TBL] [Abstract] [Full Text] [Related]
10. Structural Features of Heparan Sulfate from Multiple Osteochondromas and Chondrosarcomas.
Veraldi N; Parra A; Urso E; Cosentino C; Locatelli M; Corsini S; Pedrini E; Naggi A; Bisio A; Sangiorgi L
Molecules; 2018 Dec; 23(12):. PubMed ID: 30544937
[TBL] [Abstract] [Full Text] [Related]
11. [Clinical and molecular study in a family with multiple osteochondromatosis].
Cammarata-Scalisi F; Stock F; Avendaño A; Cozar M; Balcells S; Grinberg D
Acta Ortop Mex; 2018; 32(2):108-111. PubMed ID: 30182558
[TBL] [Abstract] [Full Text] [Related]
12. Pencil beam scanned protons for the treatment of patients with Ewing sarcoma.
Weber DC; Murray FR; Correia D; Bolsi A; Frei-Welte M; Pica A; Lomax AJ; Schneider R; Bachtiary B
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28627000
[TBL] [Abstract] [Full Text] [Related]
13. [Hereditary bone tumors].
Baumhoer D
Pathologe; 2017 May; 38(3):179-185. PubMed ID: 28421271
[TBL] [Abstract] [Full Text] [Related]
14. Integrated analysis of gene expression and genomic aberration data in osteosarcoma (OS).
Xiong Y; Wu S; Du Q; Wang A; Wang Z
Cancer Gene Ther; 2015 Nov; 22(11):524-9. PubMed ID: 26427513
[TBL] [Abstract] [Full Text] [Related]
15. Genomic profile of a Li-Fraumeni-like syndrome patient with a 45,X/46,XX karyotype, presenting neither mutations in TP53 nor clinical stigmata of Turner syndrome.
Basso TR; Villacis RA; Canto LM; Alves VM; Lapa RM; Nóbrega AF; Achatz MI; Rogatto SR
Cancer Genet; 2015 Jun; 208(6):341-4. PubMed ID: 25935441
[TBL] [Abstract] [Full Text] [Related]
16. Somatic loss of an ext2 gene mutation during malignant progression in a patient with hereditary multiple osteochondromas.
Musso N; Caronia FP; Castorina S; Lo Monte AI; Barresi V; Condorelli DF
Cancer Genet; 2015 Mar; 208(3):62-7. PubMed ID: 25744876
[TBL] [Abstract] [Full Text] [Related]
17. Periosteal chondrosarcoma: a histopathological and molecular analysis of a rare chondrosarcoma subtype.
Cleven AH; Zwartkruis E; Hogendoorn PC; Kroon HM; Briaire-de Bruijn I; Bovée JV
Histopathology; 2015 Oct; 67(4):483-90. PubMed ID: 25648524
[TBL] [Abstract] [Full Text] [Related]
18. Genetic alterations in chondrosarcomas - keys to targeted therapies?
Samuel AM; Costa J; Lindskog DM
Cell Oncol (Dordr); 2014 Apr; 37(2):95-105. PubMed ID: 24458248
[TBL] [Abstract] [Full Text] [Related]
19. Multiple hereditary exostoses (MHE): elucidating the pathogenesis of a rare skeletal disorder through interdisciplinary research.
Jones KB; Pacifici M; Hilton MJ
Connect Tissue Res; 2014 Apr; 55(2):80-8. PubMed ID: 24409815
[TBL] [Abstract] [Full Text] [Related]
20. Array-based comparative genomic hybridization for genomic-wide screening of DNA copy number alterations in aggressive bone tumors.
Kanamori M; Sano A; Yasuda T; Hori T; Suzuki K
J Exp Clin Cancer Res; 2012 Nov; 31(1):100. PubMed ID: 23199169
[TBL] [Abstract] [Full Text] [Related]
[Next]
